Patent invalidity
Teva and Bristows win obviousness claim against Bayer cancer drug
The UK High Court has invalidated a Bayer patent covering cancer drug sorafenib, known as Nexavar, in a dispute with Teva. In Germany, the Federal Pat
...
21 October 2021 by Amy Sandys